Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Workforce
Effect of Nigeria Presidential Task Force on COVID-19 Pandemic, Nigeria
Table 1
Thematic area | Lead agency | Area of focus |
---|---|---|
Epidemiology and surveillance |
Nigeria Centre for Disease Control |
Improve surveillance, early detection and timely reporting of community transmission of COVID-19 |
Laboratory |
Nigeria Centre for Disease Control |
Strengthen laboratory testing and performance |
Point of entry |
Federal Ministry of Health; Port Health Services |
Expand border security patrol and ensure every entry point are equipped for sample collection for testing |
Case management |
Federal Ministry of Health |
Provide technical assistance and epidemiological support to states to improve case management |
Infection, prevention, and control |
Nigeria Centre for Disease Control |
Embed and strengthen functional infection prevention and control programs across the country |
Risk communication and community engagement |
Federal Ministry of Information and Culture |
Strengthen communication around COVID-19 and continuously work with partners to undertake research to address key drivers of behavior change |
Security, logistics, and mass care |
Federal Ministry of Humanitarian Affairs, Disaster Management, and Social Development |
Develop standards and criteria for enforcement of protocols and sanctions |
State coordination and government relations |
Nigeria Governor’s Forum |
Strengthen state engagement and ownership of the COVID-19 response efforts |
Resource mobilization |
Office of the Secretary of the Federation |
Ensure sustainable funding for the COVID-19 response |
Research |
Federal Ministry of Health |
Conduct scientific, clinical, anthropological and socio-economic research to provide the evidence base for guiding decision making in COVID-19 planning and response in Nigeria |
Sustainable production subgroup | Federal Ministry of Industry, Trade and Investment | Ensure long-term uptake and availability of COVID-19 supplies and products from Government and credible investors |
Page created: July 12, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.